Title R&D department

Experts in neurodegenerative preclinical modelling services

Neuro-Sys is a research-intensive and innovative organisation specialising in pharmacology and in advanced in vitro and in vivo models of neurodegenerative diseases, mode of action research, and drug development in the CNS and PNS fields.

AAIC 2021

Neuro-Sys will present posters at AAIC 2021

July 26-30, 2021

"Best International drug development and discovery company for 2019"

Laurier awards
Laurier awards

Global Health & Pharma, UK

“Top 10 Bioanalytical Services Companies 2019”

Laurier awards
Laurier awards

Pharma Tech Outlook, USA

"Drug Development Company of the year for 2020"

Laurier awards
Laurier awards

Corporate Live Wire, UK

"50 Leading Companies of the year for 2020"

Laurier awards.png
Laurier awards

The Silicon Review, USA

What we do

At Neuro-Sys, we support customers in the discovery of new treatments in the CNS and PNS fields. We provide unique in vitro and in vivo platforms to accurately determine the efficacity of and pharmacological profiling of compounds, to explore their underlying mechanism of action,  and to understand their neuroprotective activity. And we support you by helping you design your programmes, and by providing analysis and advice along the way.


  • In vitro models

  • In vivo models

  • Mode of action

  • Drug development

  • Analytical


  • Biotechnology companies

  • Pharmaceutical industry

  • Nutraceutical industry

  • Start-ups

  • Academia

Laboratory and our team
Office of Neuro-Sys


Neuro-Sys ?

  • Expertise and experience of our team of best-in-class neuropharmocologists, physicians, neurologists.

  • Continued investment in research and development.

  • Advanced and innovative models.

  • Ongoing significant investment in the latest equipment and services